Canlyniadau Chwilio - Nakamya, Juliet

Diagnostic accuracy and yield of screening tests for atrial fibrillation in the family practice setting: a multicentre cohort study gan Quinn, F. Russell, Gladstone, David J., Ivers, Noah M., Sandhu, Roopinder K., Dolovich, Lisa, Ling, Andrea, Nakamya, Juliet, Ramasundarahettige, Chinthanie, Frydrych, Paul A., Henein, Sam, Ng, Ken, Congdon, Valerie, Birtwhistle, Richard V., Ward, Richard, Healey, Jeffrey S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy gan Demchuk, Andrew M., Yue, Patrick, Zotova, Elena, Nakamya, Juliet, Xu, Lizhen, Milling, Truman J., Ohara, Tomoyuki, Goldstein, Joshua N., Middeldorp, Saskia, Verhamme, Peter, Lopez-Sendon, Jose Luis, Conley, Pamela B., Curnutte, John T., Eikelboom, John W., Crowther, Mark, Connolly, Stuart J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

LVS‐HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World‐Wide Registry gan Johnson, Linda S. B., Oldgren, Jonas, Barrett, Tyler W., McNaughton, Candace D., Wong, Jorge A., McIntyre, William F., Freeman, Clifford L., Murphy, Laura, Engström, Gunnar, Ezekowitz, Michael, Connolly, Stuart J., Xu, Lizhen, Nakamya, Juliet, Conen, David, Bangdiwala, Shrikant I., Yusuf, Salim, Healey, Jeff S.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors gan Connolly, Stuart J., Milling, Truman J., Eikelboom, John W., Gibson, C. Michael, Curnutte, John T., Gold, Alex, Bronson, Michele D., Lu, Genmin, Conley, Pamela B., Verhamme, Peter, Schmidt, Jeannot, Middeldorp, Saskia, Cohen, Alexander T., Beyer-Westendorf, Jan, Albaladejo, Pierre, Lopez-Sendon, Jose, Goodman, Shelly, Leeds, Janet, Wiens, Brian L., Siegal, Deborah M., Zotova, Elena, Meeks, Brandi, Nakamya, Juliet, Lim, W. Ting, Crowther, Mark

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors gan Connolly, Stuart J., Crowther, Mark, Eikelboom, John W., Gibson, C. Michael, Curnutte, John T., Lawrence, John H., Yue, Patrick, Bronson, Michele D., Lu, Genmin, Conley, Pamela B., Verhamme, Peter, Schmidt, Jeannot, Middeldorp, Saskia, Cohen, Alexander T., Beyer-Westendorf, Jan, Albaladejo, Pierre, Lopez-Sendon, Jose, Demchuk, Andrew M., Pallin, Daniel J., Concha, Mauricio, Goodman, Shelly, Leeds, Janet, Souza, Sonia, Siegal, Deborah M., Zotova, Elena, Meeks, Brandi, Ahmad, Sadia, Nakamya, Juliet, Milling, Truman J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 scre... gan Lowres, Nicole, Olivier, Jake, Chao, Tze-Fan, Chen, Shih-Ann, Chen, Yi, Diederichsen, Axel, Fitzmaurice, David A., Gomez-Doblas, Juan Jose, Harbison, Joseph, Healey, Jeff S., Hobbs, F. D. Richard, Kaasenbrood, Femke, Keen, William, Lee, Vivian W., Lindholt, Jes S., Lip, Gregory Y. H., Mairesse, Georges H., Mant, Jonathan, Martin, Julie W., Martín-Rioboó, Enrique, McManus, David D., Muñiz, Javier, Münzel, Thomas, Nakamya, Juliet, Neubeck, Lis, Orchard, Jessica J., Pérula de Torres, Luis Ángel, Proietti, Marco, Quinn, F. Russell, Roalfe, Andrea K., Sandhu, Roopinder K., Schnabel, Renate B., Smyth, Breda, Soni, Apurv, Tieleman, Robert, Wang, Jiguang, Wild, Philipp S., Yan, Bryan P., Freedman, Ben

Cael y testun llawn Cael y testun llawn Cael y testun llawn